Determining Developmental and Clinical Markers Affecting Urinary Function of Children With Spinal Dysraphism

N/AUnknownNCT05962086

Seoul National University Hospital1,500 enrolled

Overview

To identify developmental and clinical biomarkers that affect urinary incontinence at the ages of 5, 7, and 10 according to different neuro-urological clinical factors.

This retrospective observational cohort study aims to identify developmental and clinical biomarkers that affect urinary incontinence at the ages of 5, 7, and 10 according to the types of spinal dysraphism, conus medullaris location, and urodynamics test results.

Study Type

OBSERVATIONAL

Enrollment

1,500

Conditions

Spinal Dysraphism

Eligibility

Sex: ALLMax age: 10 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- Those who received spinal dysraphism diagnosis (ICD Code: Q05.1-05.9) and have been following up and receiving treatments due to neurogenic bladder. Exclusion Criteria: \- As the study is a retrospective study, there is no exclusion criteria.

Locations (6)

Pusan National University Yangsan Hospital

Yangsan, Gyeongsangnam-do, South Korea

RECRUITING

Keimyung University Dongsan Medical Center

Daegu, South Korea

RECRUITING

Asan Medical Center

Seoul, South Korea

Outcomes

Primary Outcomes

Achieving full continence at age 5

Achieving full urinary and fecal continence at age 5

Time frame: Age 5

Achieving full continence at age 7

Achieving full urinary and fecal continence at age 7.

Time frame: Age 7

Achieving full continence at age 10

Achieving full urinary and fecal continence at age 10

Time frame: Age 10

Central Contacts

Kwanjin Park, MD/PHD

CONTACT

+82-2-2072-0695 urodori9@snu.ac.kr

Louis Kim, BS

CONTACT

+82-10-4201-0636 kim.hyunkyu11@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.